The pathogenetic role of nonenzymatic glycosylation in diabetic complications
Brownlee M Vlassara H Cerami A The pathogenetic role of nonenzymatic glycosylation in diabetic complications Crabbe MJC Diabetic Complications: Scientific and Clinical Aspects 1987 Churchill Livingstone Edinburgh, UK 94 139
Anti-platelet effects of long term treatment with gliclazide on platelet function in patients with diabetes mellitus
Ponari O Givardi E Megta S Anti-platelet effects of long term treatment with gliclazide on platelet function in patients with diabetes mellitus Thromb Res 16 1979 191 203
Effect of gliclazide on thromboxane B2, parameters of haemostasis, fluorescent 1gG and lipid peroxides in non-insulin dependent mellitus
Florkowski CM Richardson MR Le Guen C Effect of gliclazide on thromboxane B2, parameters of haemostasis, fluorescent 1gG and lipid peroxides in non-insulin dependent mellitus Diabetes Res 9 1988 87 90
Gliclazide decreases cell-mediated low density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDL
Desfaits AC Serri O Renier G Gliclazide decreases cell-mediated low density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDL Metabolism 46 1997 1150 1156